Novel CREB3L3 Nonsense Mutation in a Family With Dominant Hypertriglyceridemia

Objective—Cyclic AMP responsive element–binding protein 3–like 3 (CREB3L3) is a novel candidate gene for dominant hypertriglyceridemia. To date, only 4 kindred with dominant hypertriglyceridemia have been found to be carriers of 2 nonsense mutations in CREB3L3 gene (245fs and W46X). We investigated a family in which hypertriglyceridemia displayed an autosomal dominant pattern of inheritance. Approach and Results—The proband was a 49-year-old woman with high plasma triglycerides (⩽1300 mg/dL; 14.68 mmol/L). Her father had a history of moderate hypertriglyceridemia, and her 51-year-old brother had triglycerides levels as high as 1600 mg/dL (18.06 mmol/L). To identify the causal mutation in this family, we analyzed the candidate genes of recessive and dominant forms of primary hypertriglyceridemia by direct sequencing. The sequencing of CREB3L3 gene led to the discovery of a novel minute frame shift mutation in exon 3 of CREB3L3 gene, predicted to result in the formation of a truncated protein devoid of function (c.359delG–p.K120fsX20). Heterozygosity for the c.359delG mutation resulted in a severe phenotype occurring later in life in the proband and her brother and a good response to diet and a hypotriglyceridemic treatment. The same mutation was detected in a 13-year-old daughter who to date is normotriglyceridemic. Conclusions—We have identified a novel pathogenic mutation in CREB3L3 gene in a family with dominant hypertriglyceridemia with a variable pattern of penetrance.

[1]  J. Borén,et al.  The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management. , 2014, The lancet. Diabetes & endocrinology.

[2]  B. Nordestgaard,et al.  Loss-of-function mutations in APOC3 and risk of ischemic vascular disease. , 2014, The New England journal of medicine.

[3]  Meghan C Towne,et al.  A compound heterozygous mutation in GPD1 causes hepatomegaly, steatohepatitis, and hypertriglyceridemia , 2014, European Journal of Human Genetics.

[4]  R. Kaufman,et al.  Endoplasmic reticulum‐tethered transcription factor cAMP responsive element‐binding protein, hepatocyte specific, regulates hepatic lipogenesis, fatty acid oxidation, and lipolysis upon metabolic stress in mice , 2012, Hepatology.

[5]  S. Yusuf,et al.  Excess of Rare Variants in Non–Genome-Wide Association Study Candidate Genes in Patients With Hypertriglyceridemia , 2012, Circulation. Cardiovascular genetics.

[6]  R. Hegele,et al.  Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1. , 2012, American journal of human genetics.

[7]  R. Fresa,et al.  Two novel rare variants of APOA5 gene found in subjects with severe hypertriglyceridemia. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[8]  R. Hegele,et al.  Genetic bases of hypertriglyceridemic phenotypes , 2011, Current opinion in lipidology.

[9]  R. Hegele,et al.  The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolism , 2011, Nature Medicine.

[10]  S. Kathiresan,et al.  Genetic determinants of plasma triglycerides , 2011, Journal of Lipid Research.

[11]  Young-sil Yoon,et al.  Regulation of hepatic gluconeogenesis by an ER-bound transcription factor, CREBH. , 2010, Cell metabolism.

[12]  H. Shimano,et al.  The liver-enriched transcription factor CREBH is nutritionally regulated and activated by fatty acids and PPARalpha. , 2010, Biochemical and biophysical research communications.

[13]  M. Taskinen,et al.  Novel LMF1 nonsense mutation in a patient with severe hypertriglyceridemia. , 2009, The Journal of clinical endocrinology and metabolism.

[14]  R. Kaufman,et al.  ER Stress Controls Iron Metabolism Through Induction of Hepcidin , 2009, Science.

[15]  J. Danesh,et al.  Association of apolipoprotein E genotypes with lipid levels and coronary risk. , 2007, JAMA.

[16]  R. Hegele,et al.  Hypertriglyceridemia: its etiology, effects and treatment , 2007, Canadian Medical Association Journal.

[17]  Randal J. Kaufman,et al.  Endoplasmic Reticulum Stress Activates Cleavage of CREBH to Induce a Systemic Inflammatory Response , 2006, Cell.

[18]  L. Pennacchio,et al.  Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. , 2005, The Journal of biological chemistry.

[19]  A. Tanigami,et al.  CREB-H: a novel mammalian transcription factor belonging to the CREB/ATF family and functioning via the box-B element with a liver-specific expression. , 2001, Nucleic acids research.

[20]  L. Havekes,et al.  Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[21]  R E Rose,et al.  A cyclic AMP-responsive element-binding transcriptional activator in Drosophila melanogaster, dCREB-A, is a member of the leucine zipper family , 1992, Molecular and cellular biology.

[22]  T. Maniatis,et al.  A Drosophila CREB/ATF transcriptional activator binds to both fat body- and liver-specific regulatory elements. , 1992, Genes & development.

[23]  S. Kliewer,et al.  Fibroblast growth factor 21: from pharmacology to physiology. , 2010, The American journal of clinical nutrition.